• Separating Growth Inhibition from Cancer Cell Death

  2026-08-18

  Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that these commonly conflated measures capture different components of anticancer response. The work provides a practical framework for interpreting drug-induced proliferation arrest, cell killing, and their timing in vitro.

• Fluo-4 AM for Retinal Bioelectronic Assays

  2026-08-17

  Fluo-4 AM is a fluorescent calcium indicator that converts intracellular calcium concentration measurement into a practical readout for retinal and cell signaling research. This article develops an assay framework linking calcium imaging with the device-level findings of a biomimetic ferroelectric retinal prosthesis study.

• From AT1 Blockade to Translational Blood Pressure Science

  2026-08-17

  Azilsartan medoxomil monopotassium, also known as TAK 491, offers a mechanistically distinctive research framework for studying sustained AT1 receptor blockade. This thought-leadership guide connects receptor pharmacology, assay strategy, comparative ARB analysis, and translational interpretation across essential hypertension treatment research, cardiovascular disease research, and critical-care hemodynamics.

• Zolmitriptan: 5-HT1B Mechanism and Research

  2026-08-16

  Zolmitriptan is a selective 5-HT1B receptor agonist used in migraine research and serotonin receptor pharmacology. Its documented receptor activity supports studies of cranial vasoconstriction and trigeminal neuropeptide signaling, while the available evidence does not establish a role in lysosomal or antiviral biology.

• From miR-200c Mechanism to EdU Translation

  2026-08-15

  A translational framework for connecting miR-200c enhancer biology with quantitative proliferation readouts. The article explains how EdU Imaging Kits (Cy5) can strengthen mechanistic validation, pharmacodynamic studies, and preclinical decision-making in pancreatic cancer research.

• 10058-F4: c-Myc-Max Inhibition Workflows

  2026-08-14

  Use 10058-F4 to connect c-Myc/Max disruption with transcriptional, chromatin, cell-cycle, and mitochondrial apoptosis readouts. This workflow distinguishes direct c-Myc transcription factor inhibition from upstream pathway effects and adapts the compound for leukemia, stem-cell, and prostate cancer studies.

• Sodium Citrate for SERS Nanocluster Workflows

  2026-08-14

  Sodium citrate provides a controllable way to tune solution chemistry around polymer pen lithography, gold nanoparticle assembly, and biological sample preparation. This guide separates evidence from the reference SERS study from practical citrate-screening recommendations, with workflow parameters and troubleshooting steps for improving reproducibility.

• EZ Cap EGFP mRNA 5-moUTP: Translational Strategy

  2026-08-13

  A mechanistic and strategic guide to using EZ Cap™ EGFP mRNA (5-moUTP) as a standardized reporter for mRNA delivery, translation, immune-compatibility, and tissue targeting studies. Drawing on charge-reversed exosome delivery to cartilage, the article shows how a fluorescent reporter can become more than an endpoint: it can help separate carrier performance, transcript biology, tissue transport, and translational readiness.

• From Ovarian Aging Biology to Better Fluorescence Data

  2026-08-13

  Multi-omics work in naturally aged mice positions glutathione metabolism, oxidative stress, mitochondrial dysfunction, apoptosis, and DNA damage repair at the center of ovarian aging biology. This thought-leadership article translates those findings into practical fluorescence strategy, showing how the FITC Goat Anti-Mouse IgG (H+L) Antibody can support reproducible mouse IgG detection while clarifying assay controls, competitive trade-offs, and the limits of preclinical inference.

• From Viability Counts to Mechanistic Confidence

  2026-08-12

  A translational framework for using AO/PI Staining Solution to strengthen cell-state measurements in inflammation and apoptosis research, illustrated by diabetic nephropathy studies.

• Decitabine: A State-Aware Epigenetic Assay Guide

  2026-08-12

  Decitabine, also called 5-Aza-2'-deoxycytidine, is more than a DNA hypomethylation agent. This guide explains how to design state-aware cancer epigenetics assays that distinguish tumor-cell reprogramming from CD8+ T-cell remodeling and immunotherapy sensitization.

• Intestinal TM6SF2 Protects Against MASH

  2026-08-11

  The reference study identifies intestinal TM6SF2 as a protective regulator of the gut–liver axis, linking epithelial lipid handling to barrier integrity, microbial dysbiosis, lysophosphatidic acid signaling, and hepatic inflammation. Its conditional mouse models, fecal-transfer experiments, co-housing design, and pharmacological intervention provide a framework for studying how intestinal defects drive MASH beyond liver-intrinsic mechanisms.

• APEX2 Supports TERT Expression in Human Stem Cells

  2026-08-11

  A recent preprint identifies APEX2, but not its paralog APEX1, as a contributor to efficient TERT expression and telomerase activity in human embryonic stem cells. Its RNA-seq and chromatin-immunoprecipitation data support a model in which APEX2-associated repair of repetitive DNA, particularly MIR elements within TERT intron 2, influences gene expression.

• WY-14643 and PPARα: From Lipids to Liver Injury

  2026-08-10

  WY-14643 (Pirinixic Acid) is a selective PPARα agonist used to connect lipid metabolism regulation with inflammatory and hepatocellular stress pathways. This article presents an assay-centered framework for interpreting PPARα-dependent protection from cholestatic liver injury and pyroptosis without overstating evidence from receptor-level studies.

• Annexin V-Cy5/DAPI Apoptosis Kit Workflow

  2026-08-09

  The Annexin V-Cy5/DAPI Apoptosis Kit provides a rapid two-parameter strategy for separating viable, apoptotic, and membrane-compromised cells. This workflow translates findings from Ph+ ALL research into practical choices for flow cytometry, fluorescence microscopy, and treatment-response studies.

7828 records 3/522 page Previous Next 12345 下5页 Last page